Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1465-542X

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk ; volume:9 ; number:2 ; day:11 ; month:4 ; year:2007 ; pages:1-14 ; date:12.2007
Breast cancer research ; 9, Heft 2 (11.4.2007), 1-14, 12.2007

Contributor: Baynes, Caroline
Healey, Catherine S.
Pooley, Karen A.
Scollen, Serena
Luben, Robert N.
Thompson, Deborah J.
Pharoah, Paul DP
Easton, Douglas F.
Ponder, Bruce AJ
Dunning, Alison M.
SpringerLink (Online service)

DOI: 10.1186/bcr1669

URN: urn:nbn:de:1111-2016032362859

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:45 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Baynes, Caroline
Healey, Catherine S.
Pooley, Karen A.
Scollen, Serena
Luben, Robert N.
Thompson, Deborah J.
Pharoah, Paul DP
Easton, Douglas F.
Ponder, Bruce AJ
Dunning, Alison M.
SpringerLink (Online service)

Other Objects (12)

BRCA1 and BRCA2 mutations in a population-based study of male breast cancer

BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families

Cancer incidence in relatives of British Fanconi Anaemia patients

Incorporating tumour pathology information into breast cancer risk prediction algorithms

Clinical software development for the Web: lessons learned from the BOADICEA project

Letter to the editor: a response to Ming’s study on machine learning techniques for personalized breast cancer risk prediction

The admixture maximum likelihood test to test for association between rare variants and disease phenotypes

Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers

Parity and breast cancer risk among BRCA1 and BRCA2mutation carriers

Combined effects of single nucleotide polymorphisms TP53 R72P and MDM2 SNP309, and p53 expression on survival of breast cancer patients

The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers

Genomic risk prediction of coronary artery disease in women with breast cancer: a prospective cohort study

BRCA1 and BRCA2 mutations in a population-based study of male breast cancer

BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families

Cancer incidence in relatives of British Fanconi Anaemia patients

Incorporating tumour pathology information into breast cancer risk prediction algorithms

Clinical software development for the Web: lessons learned from the BOADICEA project

Letter to the editor: a response to Ming’s study on machine learning techniques for personalized breast cancer risk prediction

The admixture maximum likelihood test to test for association between rare variants and disease phenotypes

Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers

Parity and breast cancer risk among BRCA1 and BRCA2mutation carriers

Combined effects of single nucleotide polymorphisms TP53 R72P and MDM2 SNP309, and p53 expression on survival of breast cancer patients

The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers

Genomic risk prediction of coronary artery disease in women with breast cancer: a prospective cohort study

BRCA1 and BRCA2 mutations in a population-based study of male breast cancer

BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families

Cancer incidence in relatives of British Fanconi Anaemia patients

Incorporating tumour pathology information into breast cancer risk prediction algorithms

Clinical software development for the Web: lessons learned from the BOADICEA project

Letter to the editor: a response to Ming’s study on machine learning techniques for personalized breast cancer risk prediction

The admixture maximum likelihood test to test for association between rare variants and disease phenotypes

Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers

Parity and breast cancer risk among BRCA1 and BRCA2mutation carriers

Combined effects of single nucleotide polymorphisms TP53 R72P and MDM2 SNP309, and p53 expression on survival of breast cancer patients

The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers

Genomic risk prediction of coronary artery disease in women with breast cancer: a prospective cohort study

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

BRCA1 and BRCA2 mutations in a population-based study of male breast cancer

BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families

Cancer incidence in relatives of British Fanconi Anaemia patients

Incorporating tumour pathology information into breast cancer risk prediction algorithms

Clinical software development for the Web: lessons learned from the BOADICEA project

Letter to the editor: a response to Ming’s study on machine learning techniques for personalized breast cancer risk prediction

The admixture maximum likelihood test to test for association between rare variants and disease phenotypes

Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers

Parity and breast cancer risk among BRCA1 and BRCA2mutation carriers

Combined effects of single nucleotide polymorphisms TP53 R72P and MDM2 SNP309, and p53 expression on survival of breast cancer patients

The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers

Genomic risk prediction of coronary artery disease in women with breast cancer: a prospective cohort study

BRCA1 and BRCA2 mutations in a population-based study of male breast cancer

BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families

Cancer incidence in relatives of British Fanconi Anaemia patients

Incorporating tumour pathology information into breast cancer risk prediction algorithms

Clinical software development for the Web: lessons learned from the BOADICEA project

Letter to the editor: a response to Ming’s study on machine learning techniques for personalized breast cancer risk prediction

The admixture maximum likelihood test to test for association between rare variants and disease phenotypes

Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers

Parity and breast cancer risk among BRCA1 and BRCA2mutation carriers

Combined effects of single nucleotide polymorphisms TP53 R72P and MDM2 SNP309, and p53 expression on survival of breast cancer patients

The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers

Genomic risk prediction of coronary artery disease in women with breast cancer: a prospective cohort study

BRCA1 and BRCA2 mutations in a population-based study of male breast cancer

BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families

Cancer incidence in relatives of British Fanconi Anaemia patients

Incorporating tumour pathology information into breast cancer risk prediction algorithms

Clinical software development for the Web: lessons learned from the BOADICEA project

Letter to the editor: a response to Ming’s study on machine learning techniques for personalized breast cancer risk prediction

The admixture maximum likelihood test to test for association between rare variants and disease phenotypes

Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers

Parity and breast cancer risk among BRCA1 and BRCA2mutation carriers

Combined effects of single nucleotide polymorphisms TP53 R72P and MDM2 SNP309, and p53 expression on survival of breast cancer patients

The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers

Genomic risk prediction of coronary artery disease in women with breast cancer: a prospective cohort study

Related objects

Reset password